Development of bioflavonoid containing chemotherapeutic delivery systems for UV-damaged skin and kangri cancer

Q4 Medicine Forum of Clinical Oncology Pub Date : 2021-12-01 DOI:10.2478/fco-2021-0012
Harish Sharma, G. Sahu, C. Kaur
{"title":"Development of bioflavonoid containing chemotherapeutic delivery systems for UV-damaged skin and kangri cancer","authors":"Harish Sharma, G. Sahu, C. Kaur","doi":"10.2478/fco-2021-0012","DOIUrl":null,"url":null,"abstract":"Abstract Background The lower abdomen and inner thighs are most likely to become affected by kangri cancer because those areas are exposed to continuous exposure to kangri. Objective In this article, formulation and characterization of a water-in-oil microemulsion of 5-fluorouracil with rutin (R-5FU) for better skin penetration and inhibition of kangri cancer (skin cancer surfactant) is discussed. Method To produce R-5-FU microemulsions, surfactant-cosurfactant was mixed with oil. Distilled water was added dropwise with the help of a burette by gentle stirring at a constant temperature. The surfactant and co-surfactant were mixed into three particular ratios 1:1, 2:1, and 3:1. Further characterizations were performed, such as visual inspection and thermodynamic stability including a stress test and centrifugation. In visual inspection included assessment of the colour, homogeneity, and odour of the formulation of FU microemulsion. Result All three microemulsions, labeled RME1, RME2, and RME3, are highly stable. An oval shape of surface morphology of 5-FU was noticed by using a TEM image. The viscosity of RME3 was found to be 17.25±0.22 pa-s. The average globule size was 100–300 nm for all three RME. The results of human cadaver skin permeability are almost of the same pattern, butRME3 indicates the best skin permeability with negligible side effects on the skin. Conclusion The quantity of 5-FU released from all formulations at 3-hr ranged from 95.57% to 83.67%. None of the three formulations resulted in skin irritation, with irritancy score of zero (IS=0). Observation revealed no lysis, hemorrhage, or coagulation after application.","PeriodicalId":38592,"journal":{"name":"Forum of Clinical Oncology","volume":"12 1","pages":"86 - 98"},"PeriodicalIF":0.0000,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Forum of Clinical Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2478/fco-2021-0012","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 1

Abstract

Abstract Background The lower abdomen and inner thighs are most likely to become affected by kangri cancer because those areas are exposed to continuous exposure to kangri. Objective In this article, formulation and characterization of a water-in-oil microemulsion of 5-fluorouracil with rutin (R-5FU) for better skin penetration and inhibition of kangri cancer (skin cancer surfactant) is discussed. Method To produce R-5-FU microemulsions, surfactant-cosurfactant was mixed with oil. Distilled water was added dropwise with the help of a burette by gentle stirring at a constant temperature. The surfactant and co-surfactant were mixed into three particular ratios 1:1, 2:1, and 3:1. Further characterizations were performed, such as visual inspection and thermodynamic stability including a stress test and centrifugation. In visual inspection included assessment of the colour, homogeneity, and odour of the formulation of FU microemulsion. Result All three microemulsions, labeled RME1, RME2, and RME3, are highly stable. An oval shape of surface morphology of 5-FU was noticed by using a TEM image. The viscosity of RME3 was found to be 17.25±0.22 pa-s. The average globule size was 100–300 nm for all three RME. The results of human cadaver skin permeability are almost of the same pattern, butRME3 indicates the best skin permeability with negligible side effects on the skin. Conclusion The quantity of 5-FU released from all formulations at 3-hr ranged from 95.57% to 83.67%. None of the three formulations resulted in skin irritation, with irritancy score of zero (IS=0). Observation revealed no lysis, hemorrhage, or coagulation after application.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
含生物类黄酮的紫外线损伤皮肤和癌症化学治疗系统的研制
摘要背景下腹部和大腿内侧最容易受到康日癌症的影响,因为这些区域持续暴露于康日。目的探讨具有抗皮肤癌症渗透和抑制作用的5-氟尿嘧啶-芦丁油包水微乳液(R-5FU)的配方和性质。方法将表面活性剂-助表面活性剂与油混合制备R-5-FU微乳。蒸馏水在滴定管的帮助下通过在恒定温度下轻轻搅拌而滴加。将表面活性剂和助表面活性剂混合成三种特定的比例:1:1、2:1和3:1。进行了进一步的表征,如目视检查和热力学稳定性,包括应力测试和离心。目视检查包括评估FU微乳制剂的颜色、均匀性和气味。结果标记为RME1、RME2和RME3的三种微乳液均具有较高的稳定性。使用TEM图像观察到5-FU的表面形态为椭圆形。RME3的粘度为17.25±0.22pa-s。三种RME的平均球大小均为100–300 nm。人体尸体皮肤渗透性的结果几乎相同,但RME3表明皮肤渗透性最好,对皮肤的副作用可以忽略不计。结论5-FU在3小时内的释放量在95.57%至83.67%之间,三种制剂均未引起皮肤刺激,刺激性评分为0(IS=0)。观察显示用药后无溶解、出血或凝血。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Forum of Clinical Oncology
Forum of Clinical Oncology Medicine-Oncology
CiteScore
0.50
自引率
0.00%
发文量
3
审稿时长
6 weeks
期刊最新文献
Breast cancer recurrence and tumor size: A bibliometric analysis Outcomes of patients with localized prostate cancer treated with combined external beam radiotherapy and high-dose-rate brachytherapy boost: A single-center retrospective study Glomerulonephritis as a paraneoplastic event from prostate cancer relapse Change of dosing paradigm in oncology Total neoadjuvant therapy in rectal cancer: a review across studies
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1